Trial Profile
A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Crossover Trial of Varenicline Tartrate (CP-526,555) in Patients With Mild to Moderate Alzheimer's Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jan 2020
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Alzheimer's disease
- Focus Proof of concept; Therapeutic Use
- Sponsors Pfizer
- 17 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Sep 2008 New trial record.